학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 241건 | 목록 1~20
Academic Journal
Gómez-Rosel M; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Department of Antibody Engineering, Leadartis SL, QUBE Technology Park, Tres Cantos, Madrid, Spain.; Rubio-Pérez L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Zagorac I; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Domínguez-Alonso C; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Díez-Alonso L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Hangiu O; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Antibody Engineering, Leadartis SL, QUBE Technology Park, Tres Cantos, Madrid, Spain.; Navarro R; Department of Antibody Engineering, Leadartis SL, QUBE Technology Park, Tres Cantos, Madrid, Spain.; Torres-Ruíz R; Molecular Cytogenetics Group, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Rodríguez-Perales S; Molecular Cytogenetics Group, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Blanco FJ; Instituto de Biomedicina de Valencia (IBV), CSIC, Valencia, Spain.; Centro de Investigación Príncipe Felipe (CIPF), Unidad Asociada a IBV, Valencia, Spain.; Compte M; Department of Antibody Engineering, Leadartis SL, QUBE Technology Park, Tres Cantos, Madrid, Spain.; Álvarez-Vallina L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Banc de Sang i Teixits, Barcelona, Spain.; Blanco B; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Spain.; Departamento de Desarrollo de Medicamentos de Terapias Avanzadas, Instituto de Salud Carlos III, Madrid, Spain.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Academic Journal
Ballesteros-González I; Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer (CIC), 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer (IBMCC), CSIC-USAL, 37007, Salamanca, Spain.; Hernández-Navas I; Grupo de Terapias Dirigidas para la Oncología de Precisión & Unidad de Investigación Clínica de Cáncer de Pulmón, Instituto de Investigación Hospital 12 de Octubre, 28041, Madrid, Spain.; Clinical Research Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Brehey O; Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Lechuga CG; Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Salmón M; Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Scotece M; Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer (CIC), 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer (IBMCC), CSIC-USAL, 37007, Salamanca, Spain.; Velasco-Vicente R; Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer (CIC), 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer (IBMCC), CSIC-USAL, 37007, Salamanca, Spain.; Flores-Gómez AA; Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer (CIC), 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer (IBMCC), CSIC-USAL, 37007, Salamanca, Spain.; Cebriá A; Experimental Therapeutics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Simón-Carrasco L; Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER), Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla, 41092, Sevilla, Spain.; Universidad Pablo de Olavide, 41013, Sevilla, Spain.; Jiménez G; Instituto de Biología Molecular de Barcelona (IBMB), CSIC, 08028, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010, Barcelona, Spain.; Musteanu M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, 28040, Madrid, Spain.; Guerra C; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Domínguez O; Genomics Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Caleiras E; Histopathology Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Blanco-Aparicio C; Experimental Therapeutics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Pons T; Department of Immunology and Oncology, National Center for Biotechnology (CNB-CSIC), Spanish National Research Council, 28049, Madrid, Spain.; Ferrer I; Grupo de Terapias Dirigidas para la Oncología de Precisión & Unidad de Investigación Clínica de Cáncer de Pulmón, Instituto de Investigación Hospital 12 de Octubre, 28041, Madrid, Spain.; Clinical Research Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Paz-Ares L; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Unidad de Investigación Clínica de Cáncer de Pulmón, Instituto de Investigación Hospital 12 de Octubre, 28041, Madrid, Spain.; Complutense University of Madrid, 28040, Madrid, Spain.; Torres-Ruiz R; Molecular Cytogenetics and Genome Editing Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales, y Tecnológicas (CIEMAT), 28040, Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, 28003, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029, Madrid, Spain.; Rodríguez-Perales S; Molecular Cytogenetics and Genome Editing Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Barbacid M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Tumor Biology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain.; Drosten M; Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer (CIC), 37007, Salamanca, Spain. mdrosten@usal.es.; Instituto de Biología Molecular y Celular del Cáncer (IBMCC), CSIC-USAL, 37007, Salamanca, Spain. mdrosten@usal.es.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain. mdrosten@usal.es.
Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE
Academic Journal
Filipuk, Galina (PL-WASW-IM) AMS Author Profile; Mañas-Mañas, Juan Francisco (E-ALM) AMS Author Profile; Moreno-Balcázar, Juan José (E-ALM) AMS Author Profile; Rodríguez-Perales, Cristina (E-ALM) AMS Author Profile
Journal of Mathematical Analysis and Applications (J. Math. Anal. Appl.) (20260101), 557, no. 1, Paper No 130268, 31 pp. ISSN: 0022-247X (print).eISSN: 1096-0813.
Academic Journal
Aguilar-González A; GENYO, Centre for Genomics and Oncological Research, Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración, 114, Granada 18016, Spain.; Department of Medicinal & Organic Chemistry, Excellence Research Unit of Chemistry applied to Biomedicine and the Environment, Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, Granada 18071, Spain.; Instituto de Investigación Biosanitaria ibs, GRANADA, Granada 18012, Spain.; Martos-Jamai I; GENYO, Centre for Genomics and Oncological Research, Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración, 114, Granada 18016, Spain.; Department of Medicinal & Organic Chemistry, Excellence Research Unit of Chemistry applied to Biomedicine and the Environment, Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, Granada 18071, Spain.; Instituto de Investigación Biosanitaria ibs, GRANADA, Granada 18012, Spain.; Ramos-Hernández I; GENYO, Centre for Genomics and Oncological Research, Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración, 114, Granada 18016, Spain.; Instituto de Investigación Biosanitaria ibs, GRANADA, Granada 18012, Spain.; Molina-Estévez FJ; GENYO, Centre for Genomics and Oncological Research, Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración, 114, Granada 18016, Spain.; Instituto de Investigación Biosanitaria ibs, GRANADA, Granada 18012, Spain.; Villao NV; Department of Parasitology and Tropical Medicine, Medical Degree Programme, Faculty of Health Sciences, Catholic University of Santiago de Guayaquil, Guayaquil 090615, Ecuador.; Puig-Serra P; Human Cancer Genetics Program, Molecular Cytogenetics & Genome Editing Unit, Centro Nacional de Investigaciones Oncologicas (CNIO), Melchor Fernandez Almagro, 3, Madrid 28029, Spain.; Rodríguez-Perales S; Human Cancer Genetics Program, Molecular Cytogenetics & Genome Editing Unit, Centro Nacional de Investigaciones Oncologicas (CNIO), Melchor Fernandez Almagro, 3, Madrid 28029, Spain.; Torres R; Human Cancer Genetics Program, Molecular Cytogenetics & Genome Editing Unit, Centro Nacional de Investigaciones Oncologicas (CNIO), Melchor Fernandez Almagro, 3, Madrid 28029, Spain.; Advanced Therapies Unit, Hematopoietic Innovative Therapies Division, Centro de Investigación Energéticas Medioambientales y Tecnológicas (CIEMAT) & Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid 28040, Spain.; Labun K; Computational Biology Unit, Department of Informatics, University of Bergen, Bergen Postboks 7803 NO-5020, Norway.; Sánchez-Martín RM; GENYO, Centre for Genomics and Oncological Research, Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración, 114, Granada 18016, Spain.; Department of Medicinal & Organic Chemistry, Excellence Research Unit of Chemistry applied to Biomedicine and the Environment, Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, Granada 18071, Spain.; Instituto de Investigación Biosanitaria ibs, GRANADA, Granada 18012, Spain.; Díaz-Mochón JJ; GENYO, Centre for Genomics and Oncological Research, Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración, 114, Granada 18016, Spain.; Department of Medicinal & Organic Chemistry, Excellence Research Unit of Chemistry applied to Biomedicine and the Environment, Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, Granada 18071, Spain.; Instituto de Investigación Biosanitaria ibs, GRANADA, Granada 18012, Spain.; Martín F; GENYO, Centre for Genomics and Oncological Research, Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración, 114, Granada 18016, Spain.; Instituto de Investigación Biosanitaria ibs, GRANADA, Granada 18012, Spain.; Department of Biochemistry and Molecular Biology III and Immunology, Faculty of Medicine, Excellence Research Unit 'Modeling Nature' (MNat), University of Granada. Avda. de la Investigación 11, Granada 18071, Spain.
Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN: 1362-4962 (Electronic) Linking ISSN: 03051048 NLM ISO Abbreviation: Nucleic Acids Res Subsets: MEDLINE
Academic Journal
Sci Rep
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientific Reports
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
검색 결과 제한하기
제한된 항목
[검색어] Rodríguez-Perales, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어